Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder

MLA

Wingerchuk, D. M., et al. Network Meta-Analysis of Food and Drug Administration-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder. Mar. 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.mdc......med..492452d11cddf3e9d5477d3ee3883adf&authtype=sso&custid=ns315887.

APA

Wingerchuk, D. M., Zhang, I., Kielhorn, A., Royston, M., Levy, M., Fujihara, K., Nakashima, I., Tanvir, I., Paul, F., & Pittock, S. J. (2022). Network meta-analysis of food and drug administration-approved treatment options for adults with aquaporin-4 immunoglobulin G-positive neuromyelitis optica spectrum disorder.

Chicago

Wingerchuk, D.M., I. Zhang, A. Kielhorn, M. Royston, M. Levy, K. Fujihara, I. Nakashima, I. Tanvir, F. Paul, and S.J. Pittock. 2022. “Network Meta-Analysis of Food and Drug Administration-Approved Treatment Options for Adults with Aquaporin-4 Immunoglobulin G-Positive Neuromyelitis Optica Spectrum Disorder,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.mdc......med..492452d11cddf3e9d5477d3ee3883adf&authtype=sso&custid=ns315887.